Explicitly mapping delivery challenges to the associated GMP process steps converts biological risk into operational risk.
- Drug Delivery Trends From 2025: Top 4 For Momentum Gains In 2026
- The Blue Crayfish: Turning Nature's Efficiency Into Safe, Bioavailable Therapeutics
- Formulation And Delivery Considerations For Cell And Gene Therapies
- Emerging RNA Delivery Strategies For Solid Tumor Oncology
- What Do Patients Appreciate? Therapeutic Innovation And Accessibility
- How Can We Develop New Treatments For Patients With Early Breast Cancer?
- M&A In GLP-1 Technology: Practical Recommendations And Best Practices
- Drug Delivery Innovation: Getting Advanced Therapies To Patients
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Liquid Capsule Manufacturing: What To Know
Capsules surround a drug in an unflavored, solid barrier enclosure. This article focuses on liquid capsule manufacturing and its advantages.
-
Deploying A Circular Economy For Medical Devices
A circular economy prioritizes sustainability throughout the supply chain by eliminating waste, circulating products and materials, and regenerating nature.
-
Propelling Gene Therapies From Lab To Clinic
Many companies are turning to CDMOs to optimize biomanufacturing processes and address the growing list of complications on the path to commercialization.
-
Elastomer Plungers With Barrier Film For COVID-19 Vaccines
Minimize the risks of accelerated drug development processes and the potential use of new vaccine platform technologies with the use of an elastomer plunger laminated with FluroTec™ barrier film.
-
Closing The Care Gap: Clinician Assistive Technologies
This technology addresses workforce shortages and growing medical complexity by helping healthcare providers manage rising demands, improve efficiency, reduce errors, and extend care access.
-
Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
How MedTech And Pharma Are Responding To Rising R&D Pressures
MedTech accelerates innovation through acquisition and integration while pharma sustains research depth by distributing risk and cost. These distinct paths are reshaping product development.
-
Understanding Risks Of Biologic Drugs And Injectable Drug-Device Combination Products
As the benefits of delivering biologic drugs as part of a combination product platform are realized, this self-administration trend will continue to grow. From a regulatory perspective, the use of a risk-based approach is foundational.
-
New Polymer Overcomes Limits In Sustained Drug Delivery In Ophthalmology
Challenges specific to eye physiology complicate the development of new therapies and necessitate innovative drug delivery methods. Biodegradable polymers show promise in addressing these challenges.
-
Continuous Manufacturing For API Breakthroughs
Observe how a compound library, designed for chemical diversity and lead-like properties, uses advanced filtering to improve hit discovery, speed hit-to-lead development, and boost early-stage small molecule drug discovery.

Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:
FRANKLY FRAN
-
In this article, Fran DeGrazio identifies four notable trends in drug delivery that gained momentum in 2025 and, she predicts, will continue to do so in 2026 and beyond. They are digitalization, sustainability, patient centricity, and the advanced delivery of complex biopharmaceuticals.

